HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhong Wang Selected Research

sapphyrin

1/2007Synthesis and biologic properties of hydrophilic sapphyrins, a new class of tumor-selective inhibitors of gene expression.
11/2006Tumor localization and antitumor efficacy of novel sapphyrin compounds.
6/2005Sapphyrins induce apoptosis in hematopoietic tumor-derived cell lines and show in vivo antitumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhong Wang Research Topics

Disease

103Neoplasms (Cancer)
06/2022 - 02/2002
37Brain Ischemia (Cerebral Ischemia)
03/2022 - 01/2004
35Prostatic Neoplasms (Prostate Cancer)
01/2022 - 07/2008
33Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
03/2022 - 01/2009
30Brain Injuries (Brain Injury)
10/2022 - 12/2010
28Infections
06/2022 - 09/2003
24Inflammation (Inflammations)
03/2022 - 11/2012
22Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2022 - 11/2010
22Stroke (Strokes)
01/2022 - 06/2011
19Brain Edema (Cerebral Edema)
03/2022 - 01/2011
18Ischemia
01/2022 - 06/2006
16Ischemic Stroke
04/2022 - 12/2006
15Carcinogenesis
01/2022 - 06/2010
14Glioma (Gliomas)
01/2022 - 04/2011
13Cerebral Hemorrhage
10/2022 - 01/2017
13Erectile Dysfunction
01/2022 - 04/2011
12Infarction (Infarctions)
01/2022 - 03/2004
12Reperfusion Injury
10/2021 - 06/2006
11Carcinoma (Carcinomatosis)
01/2022 - 02/2002
10Intracranial Vasospasm
01/2017 - 01/2010
9Breast Neoplasms (Breast Cancer)
04/2022 - 01/2012
9Migraine Disorders (Migraine)
01/2022 - 01/2019
9Cognitive Dysfunction
01/2022 - 11/2013
8Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022 - 03/2004
8Myocardial Infarction
12/2021 - 01/2013
8Obesity
11/2021 - 02/2009
8Hepatocellular Carcinoma (Hepatoma)
01/2021 - 12/2002
8Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 05/2015
8Necrosis
05/2019 - 08/2009
8Body Weight (Weight, Body)
08/2018 - 10/2006
8Hypospadias
11/2017 - 12/2005
7Cerebral Infarction
10/2021 - 08/2010
7Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021 - 01/2011
7Neoplasm Metastasis (Metastasis)
01/2020 - 01/2015
6Stable Angina
06/2022 - 11/2014
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 04/2014
6Liver Neoplasms (Liver Cancer)
07/2021 - 12/2002
6Colorectal Neoplasms (Colorectal Cancer)
04/2021 - 10/2018
6Fibrosis (Cirrhosis)
02/2021 - 08/2009
5Coronary Disease (Coronary Heart Disease)
06/2022 - 06/2018
5Angina Pectoris
06/2022 - 11/2014
5Pain (Aches)
05/2022 - 01/2019
5Sepsis (Septicemia)
01/2022 - 08/2010
5Hematoma
01/2022 - 06/2017
5Glioblastoma (Glioblastoma Multiforme)
12/2021 - 01/2015
5Aneurysm (Aneurysms)
08/2021 - 07/2013
5Intracranial Aneurysm (Cerebral Aneurysm)
08/2021 - 03/2010
5Cardiovascular Diseases (Cardiovascular Disease)
04/2021 - 11/2010
5Parkinson Disease (Parkinson's Disease)
01/2021 - 09/2013
5Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 02/2002
5Leukemia
01/2019 - 07/2004
5Poisoning
01/2016 - 10/2006
5Insulin Resistance
06/2015 - 01/2007
4Enteritis
01/2022 - 01/2018
4Urinary Tract Infections (Urinary Tract Infection)
01/2022 - 10/2017

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
03/2022 - 07/2005
22Pharmaceutical PreparationsIBA
06/2022 - 10/2008
19geniposideIBA
01/2022 - 04/2006
19Biological ProductsIBA
11/2021 - 08/2005
18Therapeutic UsesIBA
06/2022 - 10/2005
18baicalinIBA
01/2022 - 01/2004
14Biomarkers (Surrogate Marker)IBA
03/2022 - 09/2005
14Messenger RNA (mRNA)IBA
12/2021 - 03/2010
13Neuroprotective AgentsIBA
03/2022 - 12/2013
13Monoclonal AntibodiesIBA
03/2021 - 02/2008
12danhongIBA
06/2022 - 06/2015
12MicroRNAs (MicroRNA)IBA
06/2022 - 08/2013
12salicylhydroxamic acid (SHAM)IBA
06/2022 - 01/2004
12Oxygen (Dioxygen)IBA
01/2022 - 08/2010
12Hormones (Hormone)IBA
01/2022 - 01/2011
11Glucose (Dextrose)FDA LinkGeneric
01/2022 - 03/2007
10Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 12/2012
10Small Interfering RNA (siRNA)IBA
01/2020 - 09/2015
10Bispecific AntibodiesIBA
01/2020 - 11/2015
9CytokinesIBA
05/2021 - 12/2002
8Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2021 - 09/2011
7Long Noncoding RNAIBA
01/2022 - 01/2018
7RNA (Ribonucleic Acid)IBA
01/2021 - 01/2012
6Transcription Factors (Transcription Factor)IBA
01/2022 - 12/2005
6Capsules (Microcapsules)IBA
01/2022 - 06/2011
6Insulin (Novolin)FDA Link
01/2022 - 01/2007
6Fatty Acids (Saturated Fatty Acids)IBA
11/2021 - 10/2006
6AntibodiesIBA
01/2021 - 09/2008
6AndrogensIBA
01/2020 - 10/2003
6MelatoninIBA
01/2018 - 01/2009
5Phosphotransferases (Kinase)IBA
01/2022 - 02/2008
5AcidsIBA
01/2022 - 04/2006
5Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2021 - 01/2012
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 12/2012
5CateninsIBA
11/2021 - 03/2016
5AntioxidantsIBA
04/2021 - 12/2010
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 09/2003
5Complementary DNA (cDNA)IBA
09/2011 - 01/2004
4Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 06/2005

Therapy/Procedure

55Therapeutics
07/2022 - 06/2003
11Solid-State Lasers
11/2022 - 01/2013
11Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 03/2005
11Drug Therapy (Chemotherapy)
04/2021 - 01/2012
9Immunotherapy
01/2021 - 01/2015
8Aftercare (After-Treatment)
10/2017 - 02/2002